Calcium Gluconate Injection 5000 mg is a sterile, non-pyrogenic injectable solution that provides a rapid and reliable source of calcium for intravenous administration. It contains 5000 mg (5 grams) of calcium gluconate per vial or ampule—equivalent to approximately 465 mg of elemental calcium—dissolved in sterile water for injection.
This life-saving medication is widely used in hospitals, emergency rooms, and critical care settings to quickly treat acute calcium deficiencies and certain life-threatening medical emergencies. It is administered by healthcare professionals, typically through a vein (IV), allowing for immediate action when fast calcium replenishment is needed.
- Calcium Gluconate for Injection
- Dosage Strength: 5000 mg per 50 mL vial
- Presentation: Single-Dose Vials
- Volume: 50 mL
- Manufacturer: Fresenius Kabi
- NDC (National Drug Code): 63323-0360-59
Calcium Gluconate for Injection is a sterile aqueous solution intended for intravenous administration. Each 50 mL single-dose vial contains 5000 mg of calcium gluconate to provide vital calcium supplementation in clinical settings.
Indications and Usage:
This product is utilized to treat conditions arising from calcium deficiencies, including:
- Hypocalcemia
- Hypoparathyroidism
- Calcium channel blocker overdose
- Hyperkalemia and hypermagnesemia when they necessitate the urgent increase of calcium levels
Pharmacological Action:
Calcium ions play a critical role in various bodily functions, including:
- Neuromuscular activity
- Cardiac function
- Blood coagulation
- Bone formation and maintenance
- Secretion of hormones and enzymes
Â
Administration and Dosage:
Administer only as instructed by a healthcare professional. Dosage guidelines are based on the patient's health condition and calcium levels, ensuring careful monitoring during administration to avoid adverse effects.
Storage:
Vials should be stored at controlled room temperature, away from excess heat and light. Do not freeze. Check for particulate matter and discoloration before use.
Warnings:
- This medication must be administered under the supervision of a qualified healthcare provider.
- Use with caution in patients with renal impairment and those predisposed to hypercalcemia.
- Potential side effects include hypotension, bradycardia, and hypercalcemia, among others.
- Avoid rapid intravenous infusion due to the risk of severe cardiac events.
- Always ensure proper aseptic techniques are followed during the dose preparation and administration.
Please refer to the full prescribing information for detailed guidelines on administration, contraindications, warnings, precautions, and potential adverse reactions.
Brand: Fresenius Kabi
NDC: 63323-0360-59
UPC: 203633-23360591
Strength: 1000mg per 50 ml
Count: 25 Single Dose Vials Per Tray
Volume: 50 mL
Type: Treatment of Acute Symptomatic Hypocalcemia
Skip to content
